Population Pharmacokinetics of Tigecycline in Critically Ill Patients and Optimal Dosage Regimens With Dose Simulations Based on Infection Type and Renal Function
Observational study reveals pharmacokinetics of tigecycline in critically ill patients, suggesting optimized dosing based on infection type and renal function.
Key Points
Effective dosing of tigecycline in critically ill patients depends on infection type and renal function.
Population pharmacokinetics demonstrate the need for tailored dosage regimens, especially in patients with high MIC.
Monte Carlo simulations identified optimal dosing scenarios, enhancing probability of target attainment for various infections.
Tigecycline dosing may need adjustment based on creatinine clearance and infection severity for effectiveness.